Shannon John Patrick Jr sold Xeris Biopharma Holdings Inc ($XERS) shares on the open market twice in the last year for a total of $349700. His most recent sale occurred on January 5 2026. These open market sales rank 7242nd among 11678 individual insiders with an average sale value of $8.6 million across 6.37 transactions each. He made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 110750 | $7.36 | 2,935,578.0000 | 177,617,307 | 3.64% | 0.06% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 111621 | $7.36 | 3,046,328.0000 | 177,617,307 | 3.53% | 0.06% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 118134 | $7.36 | 3,157,949.0000 | 177,617,307 | 3.61% | 0.07% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | A | Common Stock | 478436 | $0.00 | 3,276,083.0000 | 177,617,307 | 17.10% | 0.27% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | A | Stock Option (Right to Buy) | 639639 | $0.00 | 639,639.0000 | 177,617,307 | 9999.99% | 0.36% |
| Jan. 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Common Stock | 25136 | $1.55 | 2,794,747.0000 | 177,617,307 | 0.91% | 0.01% |
| Jan. 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | S | Common Stock | 24907 | $7.08 | 2,705,346.0000 | 177,617,307 | 0.91% | 0.01% |
| Jan. 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Common Stock | 64265 | $1.55 | 2,769,611.0000 | 177,617,307 | 2.38% | 0.04% |
| Jan. 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Stock Option (Right to Buy) | 2900 | $0.00 | 97,100.0000 | 177,617,307 | 2.90% | 0.00% |
| Jan. 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Stock Option (Right to Buy) | 25136 | $0.00 | 0.0000 | 177,617,307 | 100.00% | 0.01% |
| Jan. 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Stock Option (Right to Buy) | 64265 | $0.00 | 0.0000 | 177,617,307 | 100.00% | 0.04% |
| Jan. 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Common Stock | 2900 | $3.94 | 2,797,647.0000 | 177,617,307 | 0.10% | 0.00% |
| Nov. 13, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Common Stock | 8970 | $1.55 | 2,666,395.0000 | 177,617,307 | 0.34% | 0.01% |
| Nov. 13, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | S | Common Stock | 23242 | $7.46 | 2,643,153.0000 | 177,617,307 | 0.87% | 0.01% |
| Nov. 14, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Common Stock | 87100 | $1.55 | 2,730,253.0000 | 177,617,307 | 3.30% | 0.05% |
| Nov. 13, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Stock Option (Right to Buy) | 8970 | $0.00 | 151,365.0000 | 177,617,307 | 5.59% | 0.01% |
| Nov. 14, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | M | Stock Option (Right to Buy) | 87100 | $0.00 | 64,265.0000 | 177,617,307 | 57.54% | 0.05% |
| Aug. 1, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 36918 | $5.38 | 2,657,425.0000 | 146,772,758 | 1.37% | 0.03% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | A | Stock Appreciation Right | 600000 | $0.00 | 600,000.0000 | 146,772,758 | 9999.99% | 0.41% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | A | Common Stock | 800000 | $0.00 | 2,687,118.0000 | 146,772,758 | 42.39% | 0.55% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 110750 | $3.56 | 1,887,118.0000 | 146,772,758 | 5.54% | 0.08% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 110750 | $3.56 | 1,997,868.0000 | 146,772,758 | 5.25% | 0.08% |
| Jan. 3, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 39443 | $3.61 | 2,108,618.0000 | 146,772,758 | 1.84% | 0.03% |
| Aug. 1, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | A | Common Stock | 250000 | $0.00 | 2,419,612.0000 | 137,674,857 | 11.52% | 0.18% |
| Jan. 29, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 22150 | $2.66 | 2,258,811.0000 | 137,674,857 | 0.97% | 0.02% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 110750 | $2.46 | 2,148,061.0000 | 137,674,857 | 4.90% | 0.08% |
| Aug. 1, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | A | Stock Appreciation Right | 300000 | $0.00 | 300,000.0000 | 137,674,857 | 9999.99% | 0.22% |
| Jan. 3, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 41334 | $1.12 | 2,355,089.0000 | 135,628,721 | 1.72% | 0.03% |
| Jan. 3, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 40834 | $2.24 | 2,280,961.0000 | 137,674,857 | 1.76% | 0.03% |
| Jan. 31, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 9880 | $1.24 | 2,321,795.0000 | 135,628,721 | 0.42% | 0.01% |
| Jan. 29, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 23414 | $1.26 | 2,331,675.0000 | 135,628,721 | 0.99% | 0.02% |
| Jan. 31, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 7497 | $2.11 | 2,396,423.0000 | 0 | 0.31% | 0.00% |
| Jan. 29, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | F | Common Stock | 15692 | $2.11 | 2,403,920.0000 | 0 | 0.65% | 0.00% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Shannon John Patrick Jr | See Remarks | A | Common Stock | 750000 | $0.00 | 2,158,575.0000 | 137,674,857 | 53.25% | 0.54% |